Role of diabetes mellitus on hepatic encephalopathy

Metabolic Brain Disease

Volumn 28, Issue 2, 2013, Pages 277-279

  Ampuero, Javier ^a   Ranchal, Isidora ^a   Del Mar Díaz Herrero, María ^b   Del Campo, José Antonio ^a   Bautista, Juan D ^b   Romero Gómez, Manuel ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Ammonia; Diabetes mellitus; Glutaminase; Hepatic encephalopathy; Inflammation

Indexed keywords

GLUTAMINASE; INSULIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

CONFERENCE PAPER; DIABETES MELLITUS; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERAMMONEMIA; INSULIN RESISTANCE; LIVER CIRRHOSIS; LIVER DYSFUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PORTOSYSTEMIC ANASTOMOSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; METABOLISM; PATHOLOGY;

BACTERIA (MICROORGANISMS);

DIABETES COMPLICATIONS; DIABETES MELLITUS; GLUTAMINASE; HEPATIC ENCEPHALOPATHY; HUMANS; HYPERAMMONEMIA; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84878012106     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-012-9354-2     Document Type: Conference Paper

References (22)

1. Baffy G (2012) Editorial: hepatocellular carcinoma in type 2 diabetes: more than meets the eye. Am J Gastroenterol 107(1):53-55
2. Baglietto-Vargas D, Lopez-Tellez JF, Moreno-Gonzalez I, Gutierrez A, Aledo JC (2004) Segregation of two glutaminase isoforms in islets of Langerhans. Biochem J 381:483-487
3. Basu S, Zethelius B, Helmersson B et al (2011) Cytokine-mediated inflammation is independently associated with insulin sensitivity measured by the euglycemic insulin clamp in a community-based cohort of elderly men. Int J Clin Exp Med 4(2):164-168
4. Bustamante J, Rimola A, Ventura PJ et al (1999) Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 30:890-895
5. Chow LS, Albright RC, Bigelow ML, Toffolo G, Cobelli C, Nair KS (2006) Mechanism of insulin's anabolic effect on muscle: measurements of muscle protein synthesis and breakdown using aminoacyl-tRNA and other surrogate measures. Am J Physiol Endocrinol Metab 291:E729-E736
6. Garcia-Compean D, Jaquez-Quintana JO, Gonzalez-Gonzalez JA et al (2009) Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management. World J Gastroenterol 15:280-288
7. Goral V, Atayan Y, Kaplan A (2011) The relation between pathogenesis of liver cirrhosis, hepatic encephalopathy and serum cytokine levels: what is the role of tumor necrosis factor alpha? Hepato-Gastroenterology 58:943-948
8. Gundling F, Schmidtler F, Hapfelmeier A et al (2011) Fecal calprotectin is a useful screening parameter for hepatic encephalopathy and spontaneous bacterial peritonitis in cirrhosis. Liver Int 31:1406-1415
9. Jun DW, Kim KT, Lee OY et al (2010) Association between small intestinal bacterial overgrowth and peripheral bacterial DNA in cirrhotic patients. Dig Dis Sci 55:1465-1471
10. Kalaitzakis E, Olsson R, Henfridsson P et al (2007) Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis. Liver Int 27(9):1194-1201
11. Krabbe KS, Reichenberg A, Yirmiya R, Smed A, Pedersen BK, Bruunsgaard H (2005) Low-dose endotoxemia and human neuropsychological functions. Brain Behav Immun 19(5):453-460
12. Montoliu C, Piedrafita B, Serra MA et al (2009) IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy. J Clin Gastroenterol 43(3):272-279
13. Nelson TE, Netzeband JG, Gruol DL (2004) Chronic interleukin-6 exposure alters metabotropic glutamate receptor-activated calcium signalling in cerebellar Purkinje neurons. Eur J Neurosci 20:2387-2400
14. Odeh M, Sabo E, Srugo I, Oliven A (2004) Serum levels of tumor necrosis factor-alpha correlate with severity of hepatic encephalopathy due to chronic liver failure. Liver Int 24(2):110-116
15. Romero-Gómez M (2005) Role of phosphate-activated glutaminase in the pathogenesis of hepatic encephalopathy. Metab Brain Dis 20:319-325
16. Romero-Gómez M (2010) Pharmacotherapy of hepatic encephalopathy in cirrhosis. Expert Opin Pharmacother 11:1317-1327
17. Romero-Gómez M, Boza F, García-Valdecasas MS, García E, Aguilar-Reina J (2001) Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 96:2718-2723
18. Romero-Gómez M, Ramos-Guerrero R, Grande L et al (2004) Intestinal glutaminase activity is increased in liver cirrhosis and correlates with minimal hepatic encephalopathy. J Hepatol 41(1):49-54
19. Sigal SH, Stanca CM, Kontorinis N, Bodian C, Ryan E (2006) Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis. Am J Gastroenterol 101(7):1490-1496
20. Squires SA, Ewart HS, McCarthy C, Brosnan ME, Brosnan JT (1997) Regulation of hepatic glutaminase in the streptozotocin-induced diabetic rat. Diabetes 46(12):1945-1949
21. Watford M, Smith EM, Erbelding EJ (1984) The regulation of phosphate-activated glutaminase activity and glutamine metabolism in the streptozotocin-diabetic rat. Biochem J 224:207-214
22. Weaver JD, Huang MH, Albert M, Harris T, Rowe JW, Seeman TE (2002) Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology 59:371-378